Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: fever; muscle aches; chills; joint pain; fatigue; This is a spontaneous report from a contactable consumer. This consumer reported for an 85-year-old female consumer (patient) that:  A 85-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection ; Batch/Lot Number: EN6208), dose 2 via an unspecified route of administration, administered in Arm Left on 18Mar2021 11:45  as SINGLE DOSE for covid-19 immunisation.Medical history included diabetes mellitus , surgery, implantable defibrillator insertion The patient experienced fever on 19Mar2021 08:00 , muscle aches  on 19Mar2021 08:00 , chills  on 19Mar2021 08:00 with , joint pain on 19Mar2021 08:00 with outcome of recovering , fatigue on 19Mar2021 08:00  Therapeutic measures were taken as a result of fever muscle aches chills ,joint pain fatigue Query: Please help double confirm correct PRD of attached report due to auto accept PRD as 19Mar2021, please clarify if that date is the earliest awareness date or not.The Pfizer US Drug safety unit recently received the attached report submitted by you via (website name). Please help to confirm the date that you became aware of the adverse events in this report as this effects regulatory reporting timelines. This awareness date is the date you became aware of the occurrence of the reported events. If you are the patient in the case, your awareness date would be the date that you became aware you were experiencing the reported events. If you are not the patient in the case, your awareness date would be the date you became aware of the occurrence of the reported events. This awareness date represents the Pfizer receipt date of the report and reflects the earliest date that any Pfizer colleague learned of the adverse event. If you learned of these events from another Pfizer colleague, please provide the date that the first Pfizer colleague became aware of the events reported, as regulatory reporting due dates are calculated based on the first day that a Pfizer colleague became aware of the adverse events. Response:Yes, 19Mar2021 is when I became aware of the adverse events.Follow-up #02 (23Mar2021): This is a follow-up spontaneous report received in response to the mail trail sent regarding the confirmation below mentioned query. The response included:Query: Please help double confirm correct PRD of attached report due to auto accept PRDas 19Mar2021, please clarify if that date is the earliest awareness date or not.The Pfizer safety unit recently received the attached report submitted by you via (website name). Please help to confirm the date that you became aware of the adverse events in this report as this effects regulatory reporting timelines. This awareness date is the date you became aware of the occurrence of the reported events. If you are the patient in the case, your awareness date would be the date that you became aware you were experiencing the reported events. If you are not the patient in the case, your awareness date would be the date you became aware of the occurrence of the reported events.This awareness date represents the Pfizer receipt date of the report and reflects the earliest date that any Pfizer colleague learned of the adverse event. If you learned of these events from another Pfizer colleague, please provide the date that the first Pfizer colleague became aware of the events reported, as regulatory reporting due dates are calculated based on the first day that a Pfizer colleague became aware of the adverse events. Response: Yes, 19Mar2021 is when I became aware of the adverse events. The events were assessed as Non serious by health authority outcome of events was recovering on 19Mar2021  No follow-up attempts are possible. No further information is expected